Fluticasone Propionate And Salmeterol Powder, Metered
Product Images NDC 63629-8811

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate And Salmeterol (NDC 63629-8811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fp Chem Structure (Fluticasone Propionate Salmeterol Inhalation Powde 1)

Fp Chem Structure (Fluticasone Propionate Salmeterol Inhalation Powde 1)
FDA Label Image

Figure 8 (Fluticasone Propionate Salmeterol Inhalation Powde 10)

Figure 8 (Fluticasone Propionate Salmeterol Inhalation Powde 10)
FDA Label Image

Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 11)

Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 11)
FDA Label Image

Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 12)

Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 12)
FDA Label Image

Figurr A (Fluticasone Propionate Salmeterol Inhalation Powde 13)

Figurr A (Fluticasone Propionate Salmeterol Inhalation Powde 13)
The text describes a medical inhaler device that has a dose counter, a mouthpiece, and a yellow cap. The name of the device is not available.*
FDA Label Image

Figure B (Fluticasone Propionate Salmeterol Inhalation Powde 14)

Figure B (Fluticasone Propionate Salmeterol Inhalation Powde 14)
This text is providing simple information regarding the number of doses available in an inhaler, whether it's full or empty. It mentions that the full inhaler contains 60 doses whereas there are 0 doses available in an empty inhaler.*
FDA Label Image

Figure C (Fluticasone Propionate Salmeterol Inhalation Powde 15)

Figure C (Fluticasone Propionate Salmeterol Inhalation Powde 15)
FDA Label Image

Figure C (Fluticasone Propionate Salmeterol Inhalation Powde 16)

Figure C (Fluticasone Propionate Salmeterol Inhalation Powde 16)
FDA Label Image

Breathe Out Image (Fluticasone Propionate Salmeterol Inhalation Powde 17)

Breathe Out Image (Fluticasone Propionate Salmeterol Inhalation Powde 17)
FDA Label Image

Figure F (Fluticasone Propionate Salmeterol Inhalation Powde 18)

Figure F (Fluticasone Propionate Salmeterol Inhalation Powde 18)
FDA Label Image

Figure G (Fluticasone Propionate Salmeterol Inhalation Powde 19)

Figure G (Fluticasone Propionate Salmeterol Inhalation Powde 19)
FDA Label Image

Salmeterol Chem Structure (Fluticasone Propionate Salmeterol Inhalation Powde 2)

Salmeterol Chem Structure (Fluticasone Propionate Salmeterol Inhalation Powde 2)
FDA Label Image

Figure H (Fluticasone Propionate Salmeterol Inhalation Powde 20)

Figure H (Fluticasone Propionate Salmeterol Inhalation Powde 20)
FDA Label Image

Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 21)

Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 21)
FDA Label Image

Figure 1 (Fluticasone Propionate Salmeterol Inhalation Powde 3)

Figure 1 (Fluticasone Propionate Salmeterol Inhalation Powde 3)
FDA Label Image

Figure 2 (Fluticasone Propionate Salmeterol Inhalation Powde 4)

Figure 2 (Fluticasone Propionate Salmeterol Inhalation Powde 4)
FDA Label Image

Figure 3 (Fluticasone Propionate Salmeterol Inhalation Powde 5)

Figure 3 (Fluticasone Propionate Salmeterol Inhalation Powde 5)
FDA Label Image

Figure 4 (Fluticasone Propionate Salmeterol Inhalation Powde 6)

Figure 4 (Fluticasone Propionate Salmeterol Inhalation Powde 6)
This text refers to the results of a study conducted on various types of medications and a placebo. The medications mentioned include O FS MDPI 113 mcg/14 mcg, 05 & FS MDPI 55 mcg/14 mcg, FP MDPI 113 mcg, and A FP MDP15S mcg, with sample sizes of 61, 56, 72, and 63 respectively. The study measured the mean change in FEV (forced expiratory volume) in liters over the course of one day, with baseline measurements taken at hour 0 and measurements taken at hours 1, 2, 3, 4, 5, 6, 7, 9, 10, and 11. The results for placebo are also included with a sample size of 60.*
FDA Label Image

Figure 5 (Fluticasone Propionate Salmeterol Inhalation Powde 7)

Figure 5 (Fluticasone Propionate Salmeterol Inhalation Powde 7)
FDA Label Image

Figure 6 (Fluticasone Propionate Salmeterol Inhalation Powde 8)

Figure 6 (Fluticasone Propionate Salmeterol Inhalation Powde 8)
FDA Label Image

Figure 7 (Fluticasone Propionate Salmeterol Inhalation Powde 9)

Figure 7 (Fluticasone Propionate Salmeterol Inhalation Powde 9)
FDA Label Image

Label (Lbl636298811)

Label (Lbl636298811)
Fluticasone Propionate and Salmeterol Inhalation Powder is a prescription drug. It is a combination of Fluticasone proprionate and Salmeterol base. Each metered dose of the inhaler contains 55 mcg of Fluticasone proprionate and 14 mcg of Salmeterol base. It should be used for oral inhalation only. The drug is available in a pack of 60 metered inhalations (0.45 g). The inhaler should not be washed or put in water. It should be stored in a controlled room temperature between 15°C and 25°C (59°F and 77°F) and should be protected from extreme heat, cold, or humidity.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.